Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Fulgent Genetics, |
RCV005007428 | SCV005643357 | uncertain significance | Polycystic kidney disease, adult type | 2024-03-04 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV005392934 | SCV006046173 | uncertain significance | Inborn genetic diseases | 2025-01-20 | criteria provided, single submitter | clinical testing | The c.3715G>A (p.D1239N) alteration is located in exon 15 (coding exon 15) of the PKD1 gene. This alteration results from a G to A substitution at nucleotide position 3715, causing the aspartic acid (D) at amino acid position 1239 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |